[Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases]

Hautarzt. 2019 Jan;70(1):64-67. doi: 10.1007/s00105-018-4316-1.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Eye Diseases* / chemically induced
  • Eye Diseases* / therapy
  • Humans
  • Interdisciplinary Communication*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • dupilumab